These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32368502)

  • 1. Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma.
    Anderson CC; Khatri M; Roede JR
    Toxicol Rep; 2020; 7():520-528. PubMed ID: 32368502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells.
    Sieczkowski E; Lehner C; Ambros PF; Hohenegger M
    Int J Cancer; 2010 May; 126(9):2025-35. PubMed ID: 19739078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells.
    Kuzyk CL; Anderson CC; Roede JR
    Clin Transl Sci; 2020 May; 13(3):563-572. PubMed ID: 31917509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts.
    Moreira AC; Branco AF; Sampaio SF; Cunha-Oliveira T; Martins TR; Holy J; Oliveira PJ; Sardão VA
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2468-78. PubMed ID: 25283819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells.
    Sadeghi-Aliabadi H; Minaiyan M; Dabestan A
    Res Pharm Sci; 2010 Jul; 5(2):127-33. PubMed ID: 22049271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
    Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis.
    Bender A; Opel D; Naumann I; Kappler R; Friedman L; von Schweinitz D; Debatin KM; Fulda S
    Oncogene; 2011 Jan; 30(4):494-503. PubMed ID: 20856197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.
    Martirosyan A; Clendening JW; Goard CA; Penn LZ
    BMC Cancer; 2010 Mar; 10():103. PubMed ID: 20298590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
    Buranrat B; Suwannaloet W; Naowaboot J
    Oncol Lett; 2017 Nov; 14(5):6243-6250. PubMed ID: 29113274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.
    Mallappa S; Neeli PK; Karnewar S; Kotamraju S
    Mol Carcinog; 2019 Jul; 58(7):1118-1133. PubMed ID: 30834613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
    Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Szczęśniak-Sięga B; Wesołowska O
    Anticancer Res; 2019 Feb; 39(2):727-734. PubMed ID: 30711951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt.
    Mullen PJ; Zahno A; Lindinger P; Maseneni S; Felser A; Krähenbühl S; Brecht K
    Biochim Biophys Acta; 2011 Dec; 1813(12):2079-87. PubMed ID: 21839782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes.
    Park KW; Hwang KK; Cho HJ; Hur J; Yang HM; Yoon CH; Kang HJ; Oh BH; Park YB; Kim HS
    Clin Chim Acta; 2008 Feb; 388(1-2):156-66. PubMed ID: 18037374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of Herba Cistanches on statin-induced myotoxicity in vitro.
    Wat E; Ng CF; Koon CM; Wong EC; Tomlinson B; Lau CB
    J Ethnopharmacol; 2016 Aug; 190():68-73. PubMed ID: 27286913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of tissue factor by siRNA enhances doxorubicin-induced apoptosis in human neuroblastoma].
    Fang J; Tang H; Xia LH; Zhou MX; Chen Y; Wei WN; Hu Y; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):594-7. PubMed ID: 18246814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
    Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
    Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin induces the apoptosis of normal vascular smooth muscle through the disruption of actin integrity via the impairment of RhoA/Rac-1 activity.
    Kang S; Kim K; Noh JY; Jung Y; Bae ON; Lim KM; Chung JH
    Thromb Haemost; 2016 Aug; 116(3):496-505. PubMed ID: 27306926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
    Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
    Mol Pharmacol; 2008 Aug; 74(2):476-84. PubMed ID: 18463201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin.
    Atil B; Berger-Sieczkowski E; Bardy J; Werner M; Hohenegger M
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):17-32. PubMed ID: 26319048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.